Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod

Background. Natalizumab- (NTZ-) associated progressive multifocal leukoencephalopathy (PML) is a severe and often disabling infectious central nervous system disease that can become evident in multiple sclerosis (MS) patients after NTZ discontinuation. Recently, novel diagnostic biomarkers for the a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Case Rep Neurol Med
Asıl Yazarlar: Sinnecker, Tim, Othman, Jalal, Kühl, Marc, Metz, Imke, Niendorf, Thoralf, Kunkel, Annett, Paul, Friedemann, Wuerfel, Jens, Faiss, Juergen
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi Publishing Corporation 2016
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5138460/
https://ncbi.nlm.nih.gov/pubmed/27994897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/5876798
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller